Dr. Christopher Kellner, MD
Claim this profileMount Sinai Health System
Affiliated Hospitals
Mount Sinai Health System
Mount Sinai
Clinical Trials Christopher Kellner, MD is currently running
CereVasc eShunt
for Normal Pressure Hydrocephalus
Prospective, multi-center, randomized, controlled trial of the eShunt System in the treatment of patients with normal pressure hydrocephalus.
Recruiting
1 award
N/A
9 criteria
Transcranial Ultrasound
for Stroke
Postoperative rebleeding is a major limitation of surgical evacuation for intracerebral hemorrhage (ICH). While computed tomography (CT) is the standard of care for postoperative hematoma cavity monitoring, CT requires significant physical and financial costs. Studies have demonstrated varying degrees of efficacy when using transcranial ultrasound to measure ICH volume. Recently, synthetic implants for cranioplasty have been shown to be safe and sonolucent. This study aims to evaluate the ability of transcranial ultrasound with sonolucent cranioplasty (TUSC) to detect and quantify bleeding in postoperative ICH patients.
Recruiting
1 award
N/A
5 criteria
More about Christopher Kellner, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Christopher Kellner, MD has experience with
- TRUFILL N-BCA
- IRRAflow® Active Fluid Exchange System
- Traditional Extraventricular Drain
- Artemis Neuro Evacuation Device
- Best Medical Management Alone (MM)
- CereVasc EShunt System
Breakdown of trials Christopher Kellner, MD has run
Chronic Subdural Hematoma
Subdural Hematoma
Intraventricular Hemorrhage
Cerebrovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Kellner, MD specialize in?
Christopher Kellner, MD focuses on Chronic Subdural Hematoma and Subdural Hematoma. In particular, much of their work with Chronic Subdural Hematoma has involved treating patients, or patients who are undergoing treatment.
Is Christopher Kellner, MD currently recruiting for clinical trials?
Yes, Christopher Kellner, MD is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Christopher Kellner, MD has studied deeply?
Yes, Christopher Kellner, MD has studied treatments such as TRUFILL n-BCA, IRRAflow® Active Fluid Exchange System, Traditional extraventricular drain.
What is the best way to schedule an appointment with Christopher Kellner, MD?
Apply for one of the trials that Christopher Kellner, MD is conducting.
What is the office address of Christopher Kellner, MD?
The office of Christopher Kellner, MD is located at: Mount Sinai Health System, New York, New York 10029 United States. This is the address for their practice at the Mount Sinai Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.